ADHD may be less about attention than the struggle to stay engaged

Research and clinical theories suggest ADHD involves motivation, reward, time perception and impulse control as much as attention, challenging the way the condition is understood and treated.

Psychiatrist Awais Aftab argues that attention deficit/hyperactivity disorder may be better understood as a disorder of sustained engagement than as a simple failure of attention. Writing in The New York Times, he says many of the day-to-day struggles associated with ADHD, including missed deadlines, disorganisation, restlessness and impulsive behaviour, may reflect problems with motivation, reward and time perception rather than a narrow inability to concentrate.

That reframing is supported by research showing that stimulant medicines do not merely switch on attention networks in the brain. A systematic review and meta-analysis published in PubMed found that methylphenidate consistently increased activity in the right inferior frontal cortex and insula, areas involved in cognitive control. A newer meta-analysis also reported overlapping effects of stimulants and non-stimulants in the left supplementary motor area, another region linked to control and goal-directed behaviour. Together, those findings suggest that treatment may work by making ordinary tasks feel more salient and worth pursuing.

Aftab points to earlier work by developmental psychologist Edmund Sonuga-Barke, who in the early 1990s found that some hyperactive children were less troubled by waiting itself than by the conditions under which they had to wait. That idea helped move the field away from a single-deficit model. Later research reviewed in PubMed has likewise found that people with ADHD show differences in brain regions tied to inhibition and attention, while long-term stimulant use is associated with more typical activation in the right caudate during attention tasks. The broader picture is of a condition with multiple pathways, not one simple cause.

The article also draws on the work of clinical neuropsychologist Russell Barkley, whose theory places greater emphasis on inhibition, working memory, motivation and emotional regulation. That approach helps explain why many people with ADHD describe not just distractibility, but also time blindness, frustration intolerance and difficulty starting tasks unless there is outside pressure. A separate study of methylphenidate found that the drug can increase dopamine in brain regions associated with reward and motivation, reinforcing the idea that medicines may raise a task’s perceived importance rather than sharpen attention in the narrow scientific sense.

Aftab warns that the name of the disorder can mislead both clinicians and the public. If the label suggests a pure attention problem, people whose main difficulties are boredom, lateness, emotional volatility or procrastination may be overlooked. At the same time, he notes that ADHD remains a genuine and often disabling condition. Observational studies have linked treatment with lower rates of death, self-harm, transport accidents, criminal convictions and substance misuse, which is one reason many specialists still consider medication an important part of care.

His broader point is that ADHD sits at the intersection of biology and environment. Modern life places heavy demands on planning, self-control and sustained effort, so limitations in those abilities can become disabling even when they do not amount to a single, easily defined brain defect. That is why Aftab argues for a more careful understanding of the condition: not as a failure of attention alone, but as a complex difficulty with motivation, impulse control and engagement that becomes visible in everyday life.